KR102238374B1 - Manufacturing method of gongjindan - Google Patents
Manufacturing method of gongjindan Download PDFInfo
- Publication number
- KR102238374B1 KR102238374B1 KR1020200114940A KR20200114940A KR102238374B1 KR 102238374 B1 KR102238374 B1 KR 102238374B1 KR 1020200114940 A KR1020200114940 A KR 1020200114940A KR 20200114940 A KR20200114940 A KR 20200114940A KR 102238374 B1 KR102238374 B1 KR 102238374B1
- Authority
- KR
- South Korea
- Prior art keywords
- gongjindan
- weight
- parts
- hours
- dough
- Prior art date
Links
- 239000009691 Gongjin-dan Substances 0.000 title claims abstract description 43
- 238000004519 manufacturing process Methods 0.000 title claims description 18
- 230000032683 aging Effects 0.000 claims abstract description 25
- 239000000284 extract Substances 0.000 claims abstract description 18
- 235000019997 soju Nutrition 0.000 claims abstract description 15
- 238000002156 mixing Methods 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims abstract description 12
- 210000003056 antler Anatomy 0.000 claims description 21
- 238000000855 fermentation Methods 0.000 claims description 19
- 230000004151 fermentation Effects 0.000 claims description 19
- 235000012907 honey Nutrition 0.000 claims description 16
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 13
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 12
- 241000209020 Cornus Species 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000000796 flavoring agent Substances 0.000 claims description 10
- 235000019634 flavors Nutrition 0.000 claims description 10
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 8
- 238000004898 kneading Methods 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 claims description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 6
- 241000235645 Pichia kudriavzevii Species 0.000 claims description 6
- 241001116389 Aloe Species 0.000 claims description 5
- 241000235004 Saccharomycopsis fibuligera Species 0.000 claims description 5
- 235000011399 aloe vera Nutrition 0.000 claims description 5
- 238000005194 fractionation Methods 0.000 claims description 5
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 4
- 235000011613 Pinus brutia Nutrition 0.000 claims description 4
- 241000018646 Pinus brutia Species 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 241000282994 Cervidae Species 0.000 claims description 3
- 241000186679 Lactobacillus buchneri Species 0.000 claims description 3
- 241000925032 Lactobacillus harbinensis Species 0.000 claims description 3
- 241000183331 Lactobacillus paracasei subsp. tolerans Species 0.000 claims description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 3
- 230000000284 resting effect Effects 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 239000002023 wood Substances 0.000 claims description 3
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 238000000227 grinding Methods 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 244000061520 Angelica archangelica Species 0.000 claims 2
- 201000006549 dyspepsia Diseases 0.000 abstract description 12
- 208000002193 Pain Diseases 0.000 abstract description 9
- 206010019233 Headaches Diseases 0.000 abstract description 7
- 231100000869 headache Toxicity 0.000 abstract description 7
- 206010008479 Chest Pain Diseases 0.000 abstract description 6
- 201000004624 Dermatitis Diseases 0.000 abstract description 5
- 208000005171 Dysmenorrhea Diseases 0.000 abstract description 5
- 208000037093 Menstruation Disturbances Diseases 0.000 abstract description 5
- 206010046788 Uterine haemorrhage Diseases 0.000 abstract description 5
- 231100000544 menstrual irregularity Toxicity 0.000 abstract description 5
- 210000004369 blood Anatomy 0.000 abstract description 4
- 239000008280 blood Substances 0.000 abstract description 4
- 230000003247 decreasing effect Effects 0.000 abstract description 4
- 208000002173 dizziness Diseases 0.000 abstract description 4
- 206010016256 fatigue Diseases 0.000 abstract description 4
- 230000003908 liver function Effects 0.000 abstract description 4
- 206010000087 Abdominal pain upper Diseases 0.000 abstract 1
- 206010060800 Hot flush Diseases 0.000 abstract 1
- 206010027339 Menstruation irregular Diseases 0.000 abstract 1
- 241000402754 Erythranthe moschata Species 0.000 description 20
- 230000000052 comparative effect Effects 0.000 description 16
- 241000125175 Angelica Species 0.000 description 11
- 238000001467 acupuncture Methods 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 229940124595 oriental medicine Drugs 0.000 description 5
- 208000004998 Abdominal Pain Diseases 0.000 description 4
- 241000282988 Capreolus Species 0.000 description 4
- 206010016825 Flushing Diseases 0.000 description 4
- 235000019658 bitter taste Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 2
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 2
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 2
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 2
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 241000208340 Araliaceae Species 0.000 description 2
- CUKSFECWKQBVED-INIZCTEOSA-N Decursin Chemical compound C1=CC(=O)OC2=C1C=C1C[C@H](OC(=O)C=C(C)C)C(C)(C)OC1=C2 CUKSFECWKQBVED-INIZCTEOSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 229930186217 Glycolipid Natural products 0.000 description 2
- CUKSFECWKQBVED-UHFFFAOYSA-N Grandivittin Natural products C1=CC(=O)OC2=C1C=C1CC(OC(=O)C=C(C)C)C(C)(C)OC1=C2 CUKSFECWKQBVED-UHFFFAOYSA-N 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- YTZSBJLNMIQROD-SFBCHFHNSA-N Morroniside Chemical compound O([C@@H]1OC=C([C@H]2C[C@H](O)O[C@@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YTZSBJLNMIQROD-SFBCHFHNSA-N 0.000 description 2
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 2
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 2
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- HLXRWTJXGMHOFN-XJSNKYLASA-N Verbenalin Chemical compound O([C@@H]1OC=C([C@H]2C(=O)C[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HLXRWTJXGMHOFN-XJSNKYLASA-N 0.000 description 2
- -1 angelate Chemical compound 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- JXZWWIMXTVJNSF-UHFFFAOYSA-N decursin Natural products CC(=CC(=O)OC1Oc2cc3OC(=O)C=Cc3cc2CC1(C)C)C JXZWWIMXTVJNSF-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 230000000873 masking effect Effects 0.000 description 2
- 231100000551 menstrual abnormality Toxicity 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- YGWFATZZDWWLRC-UHFFFAOYSA-N (+)-Marmesin Natural products O1C(=O)C=CC2=C1C=C1OCC(C(C)(O)C)C1=C2 YGWFATZZDWWLRC-UHFFFAOYSA-N 0.000 description 1
- YTZSBJLNMIQROD-UHFFFAOYSA-N (4aS)-1c-beta-D-glucopyranosyloxy-6xi-hydroxy-8t-methyl-(4ar,8ac)-5,6,8,8a-tetrahydro-1H,4aH-pyrano[3,4-c]pyran-4-carboxylic acid methyl ester Natural products C12C(C)OC(O)CC2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O YTZSBJLNMIQROD-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000544270 Angelica acutiloba Species 0.000 description 1
- 240000001810 Angelica gigas Species 0.000 description 1
- 235000018865 Angelica gigas Nutrition 0.000 description 1
- 241000382455 Angelica sinensis Species 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 206010008469 Chest discomfort Diseases 0.000 description 1
- 241000142975 Cornaceae Species 0.000 description 1
- 241000759833 Cornus officinalis Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- BGXFQDFSVDZUIW-UHFFFAOYSA-N Decursinol Natural products O1C(=O)C=CC2=C1C=C1OC(C)(C)C(O)CC1=C2 BGXFQDFSVDZUIW-UHFFFAOYSA-N 0.000 description 1
- 241001369972 Deudorix epijarbas Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 208000036993 Frustration Diseases 0.000 description 1
- 241000186605 Lactobacillus paracasei Species 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- AMBQHHVBBHTQBF-UHFFFAOYSA-N Loganin Natural products C12C(C)C(O)CC2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O AMBQHHVBBHTQBF-UHFFFAOYSA-N 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- HXCGUCZXPFBNRD-DNLMCPORSA-N Nodakenin Chemical compound CC(C)([C@@H]1OC2=CC=3OC(=O)C=CC=3C=C2C1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HXCGUCZXPFBNRD-DNLMCPORSA-N 0.000 description 1
- HXCGUCZXPFBNRD-QVYYAULWSA-N Nodakenin Natural products O(C(C)(C)[C@@H]1Oc2c(cc3c(OC(=O)C=C3)c2)C1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HXCGUCZXPFBNRD-QVYYAULWSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- HLXRWTJXGMHOFN-UHFFFAOYSA-N Verbenalin Natural products C12C(C)CC(=O)C2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O HLXRWTJXGMHOFN-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- AGABNGOXUSXQDD-XKGFZTIGSA-N [(3s)-2,2-dimethyl-8-oxo-3,4-dihydropyrano[3,2-g]chromen-3-yl] (z)-2-methylbut-2-enoate Chemical compound C1=CC(=O)OC2=C1C=C1C[C@H](OC(=O)C(\C)=C/C)C(C)(C)OC1=C2 AGABNGOXUSXQDD-XKGFZTIGSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- 230000001772 anti-angiogenic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000011046 carnelian Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical class C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- BGXFQDFSVDZUIW-LBPRGKRZSA-N decursinol Chemical compound O1C(=O)C=CC2=C1C=C1OC(C)(C)[C@@H](O)CC1=C2 BGXFQDFSVDZUIW-LBPRGKRZSA-N 0.000 description 1
- AGABNGOXUSXQDD-UHFFFAOYSA-N decursinol angelate Natural products C1=CC(=O)OC2=C1C=C1CC(OC(=O)C(C)=CC)C(C)(C)OC1=C2 AGABNGOXUSXQDD-UHFFFAOYSA-N 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 150000002270 gangliosides Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 210000004884 grey matter Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 239000006049 herbal material Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- AMBQHHVBBHTQBF-UOUCRYGSSA-N loganin Chemical compound O([C@@H]1OC=C([C@H]2C[C@H](O)[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O AMBQHHVBBHTQBF-UOUCRYGSSA-N 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 239000011858 nanopowder Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- FWYSBEAFFPBAQU-GFCCVEGCSA-N nodakenetin Chemical compound C1=CC(=O)OC2=C1C=C1C[C@H](C(C)(O)C)OC1=C2 FWYSBEAFFPBAQU-GFCCVEGCSA-N 0.000 description 1
- HXCGUCZXPFBNRD-UHFFFAOYSA-N nodakenine Natural products C1C2=CC=3C=CC(=O)OC=3C=C2OC1C(C)(C)OC1OC(CO)C(O)C(O)C1O HXCGUCZXPFBNRD-UHFFFAOYSA-N 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medical Informatics (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 향부자를 포함하는 공진단 제조방법에 관한 것이다.The present invention relates to a method for manufacturing a gongjindan comprising a hyangbuja.
공진단(拱辰丹)은 동의보감에 소개되어 있는 한의학상의 처방으로서, 사향, 녹용, 인삼, 당귀, 산수유 및 숙지황의 6가지 생약성분으로 구성되어 있으며, 선천성 허약체질, 무력감, 만성병에 의한 체력 저하, 간 기능 저하로 인한 어지러움, 두통, 만성피로, 월경 이상 등에 효능이 있는 것으로 알려져 있다.Gongjindan (拱辰丹) is an oriental medicine prescription introduced in Donguibogam. It is composed of six herbal ingredients such as musk, antler, ginseng, angelica, cornus milk, and sukjihwang. It is known to be effective for dizziness, headache, chronic fatigue, and menstrual abnormalities caused by decreased liver function.
공진단의 주요 성분인 사향(musk)은 사향노루의 사향선(腺)을 건조시켜서 얻는 천연 동물성 향료인데, 사향노루는 현재 멸종위기에 처한 야생 동식물종의 국제거래에 관한 협약(CITES)에 의해서 포획량이 제한되어 있다. 그래서 사향은 가격이 매우 높고 수급이 원활하지 못한 문제가 있기 때문에 이를 대체할 수 있는 생약성분으로서 목향(木香)과 침향(沈香) 등이 주목을 받고 있다.Musk, the main ingredient of Gongjindan, is a natural animal flavor obtained by drying the musk gland of musk roe deer, and the amount of musk roe deer is captured according to the Convention on International Trade in Wild Animal and Plant Species (CITES), which are currently endangered. This is limited. Therefore, musk incense is very expensive and there is a problem that the supply and demand is not smooth. As a substitute for it, mokhyang (木香) and acupuncture (沈香) are attracting attention.
한편, 공진단은 전통적으로 구슬 모양의 환제(丸劑)로 제조된다. 오늘날 다수 제약사들이 동의보감의 처방을 근거로 공진단 환제를 생산, 판매하고 있으며, 공진단의 효능을 증진시키기 위하여 여러 가지 기술들이 개발되고 있다. On the other hand, Gongjindan is traditionally made of bead-shaped pills. Today, many pharmaceutical companies produce and sell Gongjindan pills based on the prescription of Donguibogam, and various technologies are being developed to improve the efficacy of Gongjindan.
일례로, 대한민국 공개특허 제10-2015-0073913호(2015. 07. 01.)에는, 사향, 목향, 침향, 녹용 등의 함유 상태를 용이하게 확인할 수 있고, 나아가 방향성 약재인 사향, 목향, 침향 등의 효과를 오랫동안 유지할 수 있는 공진단 및 그 제조방법이 소개되어 있다. 상기 특허의 공진단은, 사향, 목향, 침향, 녹용 및 이들의 혼합물과 제 1보료로 구성되는 내핵과, 당귀, 녹용, 산수유 및 제 2보료로 구성되는 외피로 이루어지고, 상기 외피가 상기 내핵을 감싸도록 형성한 것이다. 또한, 공개특허 제10-2016-0049750호(2016. 05. 10.)에는, 장에서의 흡수율을 향상시킬 수 있는 발효 공진단 조성물 및 그 제조방법이 개시되어 있다. 상기 발효 공진단의 제조방법은, 산수유, 녹용, 당귀, 사향을 천연꿀과 배합하는 단계와; 배합한 원료를 발효하는 단계; 발효된 원료를 정량 검품하는 단계; 및 정량 검품된 원료를 약효 보호용 금박으로 포장하는 단계; 를 포함한다. 마지막으로 공개특허 제10-2016-0049751호(2016년 05월 10일)에는, 웅담을 함유하는 공진단 조성물 및 그 제조방법이 개시되어 있다. 상기 웅담 공진단 조성물의 제조방법은, 웅담, 산수유, 녹용, 당귀, 사향을 천연꿀과 배합하는 단계; 배합한 원료를 발효하는 단계; 발효된 원료를 정량 검품하는 단계; 및 정량 검품된 원료를 약효 보호용 금박으로 포장하는 단계; 를 포함한다. For example, in Korean Patent Application Publication No. 10-2015-0073913 (2015. 07. 01.), it is possible to easily check the content of musk, musk, aloes, and antlers, and furthermore, aromatic medicinals musk, musk, and aloes Resonance diagnosis and its manufacturing method that can maintain the effect of such as for a long time are introduced. Gongjindan of the patent consists of an inner core composed of musk, musk, acupuncture, antler and a mixture thereof and a first supplement, and an outer shell composed of angelica, antler, cornus oil, and a second supplement, and the outer shell comprises the inner core. It was formed to wrap around. In addition, Korean Patent Publication No. 10-2016-0049750 (2016. 05. 10.) discloses a fermentation resonant composition and a method of manufacturing the same, which can improve the absorption rate in the intestine. The manufacturing method of the fermentation gongjindan includes the steps of mixing cornus milk, antler, angelica and musk with natural honey; Fermenting the blended raw materials; Quantitatively inspecting the fermented raw material; And packaging the quantitatively inspected raw material with gold foil for drug efficacy protection. Includes. Finally, Publication No. 10-2016-0049751 (May 10, 2016) discloses a composition containing ungdam and a method of manufacturing the same. The manufacturing method of the Ungdam Gongjindan composition comprises the steps of combining Ungdam, Cornus, antler, Angelica, and musk with natural honey; Fermenting the blended raw materials; Quantitatively inspecting the fermented raw material; And packaging the quantitatively inspected raw material with gold foil for drug efficacy protection. Includes.
한편, 방동사니과에 속하는 여러해살이 풀인 방동사니는 향부(香附)라고도 불리며, 향부의 뿌리줄기를 향부자(Cyprus rotundus L.)라고 한다. 방동사니는 우리나라를 비롯해서 중국과 일본, 대만 등 열대에서 아열대 지방의 바닷가와 냇가의 양지바른 곳에서 잘 자란다. 특히, 향부자는 기운을 순환시키고 뭉친 것을 풀어주는 등 혈기를 다스리는 것으로 알려져 있고, 또한 통증을 완화시키고 월경을 조절하는 기능이 있어서 한방에서 다양한 처방에서 사용되고 있다. 예를 들어 두통이나 복통, 생리불순, 생리통, 자궁출혈, 산후풍, 심리적 불안정으로 인한 가슴통증이나 답답함, 소화불량, 안면홍조, 피부염 등에 사용하는 것으로 알려져 있다.On the other hand, Bangdongsani, a perennial herb belonging to the Bangdongsani family, is also called Hyangbu, and the rootstock of Hyangbu is called Hyangbuja (Cyprus rotundus L.). Bangdongsani grows well in the sunny areas of subtropical beaches and streams in the tropics, including Korea, China, Japan, and Taiwan. In particular, Hyangbuja is known to control blood circulation such as circulating energy and releasing lumps, and also has a function of relieving pain and controlling menstruation, so it is used in various prescriptions in oriental medicine. For example, it is known to be used for headache, abdominal pain, menstrual irregularities, menstrual pain, uterine bleeding, postpartum wind, chest pain or stuffiness due to psychological instability, indigestion, facial flushing, and dermatitis.
본 발명은 기운을 순환시키고 혈기를 다스리는 것으로 알려진 향부자를 포함하는 한편, 전통주인 소주를 배합하고 저온숙성함으로써, 기운을 보하고, 특히 두통이나 복통, 생리불순, 생리통, 자궁출혈, 산후풍, 심리적 불안정으로 인한 가슴통증이나 답답함, 소화불량, 안면홍조, 피부염 등에 효과가 있는 공진단의 제조방법을 제공하는 것을 그 목적으로 한다.The present invention includes yangbuja, which is known to circulate energy and control blood, while blending soju, a traditional liquor, and aging at a low temperature to provide energy, especially headache or abdominal pain, menstrual irregularities, menstrual pain, uterine bleeding, postpartum wind, psychological instability. Its purpose is to provide a method of manufacturing Gongjindan that is effective for chest pain, frustration, indigestion, facial flushing, and dermatitis caused by.
또한, 본 발명이 해결하고자 하는 기술적 과제는 이상에서 언급한 기술적 과제로 제한되지 않으며, 언급되지 않은 또 다른 기술적 과제들은 아래의 기재로부터 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 명확하게 이해될 수 있을 것이다. In addition, the technical problems to be solved by the present invention are not limited to the technical problems mentioned above, and other technical problems that are not mentioned are clearly to those of ordinary skill in the technical field to which the present invention belongs from the following description. It will be understandable.
본 명세서에서는 a) 녹용, 당귀, 산수유를 혼합한 후 미세분말화 하는 단계; b) 상기 혼합 미세분말 100 중량부에 전통소주 또는 청주 40 내지 60 중량부 및 벌꿀 20 내지 30 중량부를 혼합하여 반죽한 다음 55 내지 60 ℃ 온도 범위 내에서 저온 숙성하는 단계; c) 상기 숙성된 반죽 100 중량부에 전통소주 또는 청주를 90 내지 110 중량부, 벌꿀 45 내지 55 중량부를 재차 혼합한 다음, 90 내지 110 ℃ 온도 범위의 스팀팟(steam pot)에서 0.5 내지 1.5 시간 고온 숙성하는 단계; d) 상기 숙성된 반죽을 저어준 다음, 0.5 내지 1.5 시간 휴지시키고, 90 내지 110 ℃ 온도 범위의 스팀팟(steam pot)에서 0.5 내지 1.5 시간 재차 고온 숙성하는 단계; e) 상기 숙성된 반죽을 소나무 원목판에 대어 여러 번 치대어 공기를 제거하는 단계; f) 상기 반죽에 침향 및 향부자를 혼합한 다음, 0.5 내지 1.5 시간 추가로 반죽하는 단계; 및 e) 상기 f 단계에서 얻어진 반죽을 5g씩 떼어내어 구형의 환으로 제조한 다음 금박을 입히는 단계; 를 포함하는, 공진단 제조방법을 제공한다.In the present specification, a) antler, angelica, and cornus oil are mixed and finely powdered; b) mixing 40 to 60 parts by weight of traditional soju or cheongju and 20 to 30 parts by weight of honey to 100 parts by weight of the mixed fine powder, kneading, and then aging at a low temperature within a temperature range of 55 to 60°C; c) 90 to 110 parts by weight of traditional soju or cheongju and 45 to 55 parts by weight of honey are mixed again with 100 parts by weight of the aged dough, and then 0.5 to 1.5 hours in a steam pot in the temperature range of 90 to 110°C. High-temperature aging; d) stirring the aged dough, resting for 0.5 to 1.5 hours, and aging again at high temperature for 0.5 to 1.5 hours in a steam pot in a temperature range of 90 to 110°C; e) applying the aged dough to the solid pine wood board and kneading it several times to remove air; f) mixing the aloes and flavoring in the dough, and then kneading for 0.5 to 1.5 hours; And e) removing the dough obtained in step f by 5g to form a spherical ring, and then coating the dough with gold leaf. It provides a method for manufacturing a gongjindan comprising a.
또한, 본 명세서에서 상기 a 단계에서 녹용, 당귀 및 산수유는 1 : 0.8 내지 0.9 : 0.5 내지 0.7 중량부 비로 혼합되는 것인, 공진단 제조방법을 제공한다.In addition, in the present specification, in step a, antler, angelica and cornus oil are mixed in a ratio of 1: 0.8 to 0.9: 0.5 to 0.7 parts by weight, providing a method for manufacturing Gongjindan.
또한, 본 명세서에서 상기 f 단계의 향부자는 향부자 추출물에 1종 이상의 균주를 접종하여 발효시킨 것으로서, 락토바실러스 부크네리(Lactobacillus buchneri), 락토바실러스 파라카제이(Lactobacillus paracasei subsp. tolerans), 락토바실러스 하르비넨시스(Lactobacillus harbinensis), 사카로마이콥시스 피불리게라(Saccharomycopsis fibuligera) 및 피치아 쿠드리아브제비(Pichia kudriavzevii)로 이루어지는 군에서 선택되는 1종 이상의 균주를 혼합하여 발효시킨 것인, 공진단 제조방법을 제공한다. In addition, in the present specification, the f-stage Hyangbuja was fermented by inoculating Hyangbuja extract with one or more strains, Lactobacillus buchneri , Lactobacillus paracasei subsp. tolerans ), and Lactobacillus har. Vinensis ( Lactobacillus harbinensis ), Saccharomycopsis fibuligera (Saccharomycopsis fibuligera) And Pichia kudriavzevii (Pichia kudriavzevii) It provides a method for producing a gongjindan that is fermented by mixing at least one strain selected from the group consisting of.
또한, 본 명세서에서 상기 발효는 31 내지 38 ℃ 온도 조건에서 24 내지 36시간 동안 수행되는, 공진단 제조방법을 제공한다.In addition, in the present specification, the fermentation is performed for 24 to 36 hours at a temperature condition of 31 to 38° C., providing a method for producing a gongjindan.
또한, 본 명세서에서 상기 발효 후 향부자는 부탄올, 아세톤, 인산, 헥산, 에탄올 및 물로 이루어지는 군에서 선택되는 1종 이상의 분획용매로 분획하여 얻은 발효 분획추출물인, 공진단 제조방법을 제공한다.In addition, the present specification provides a fermentation fraction extract obtained by fractionation with one or more fractionation solvents selected from the group consisting of butanol, acetone, phosphoric acid, hexane, ethanol, and water.
본 발명에 따른 공진단 제조방법에 따르면, 전통주를 배합하고, 저온숙성하는과정을 통해 간 기능 저하로 인한 만성피로감, 어지러움 개선, 무력감 개선 효과가 뛰어나며, 또한, 특정 균주를 접종하여 발효시킨 향부자 발효 분획추출물로 인하여 향부자의 효능으로서 소화불량, 통증완화 등 효능이 현저히 향상된 공진단을 제공한다.According to the method of manufacturing Gongjindan according to the present invention, it is excellent in the effect of improving chronic fatigue, dizziness, and powerlessness due to decreased liver function through the process of mixing traditional liquor and aging at low temperature, and also, a fermented fraction of fragrant fermented by inoculating a specific strain. The extract provides Gongjindan with remarkably improved efficacy such as indigestion and pain relief as the efficacy of Hyangbuja.
도 1은 본 발명의 일실시예에 따른 공진단 제조 과정을 도식화한 것이다.1 is a schematic diagram of a manufacturing process of a resonance stage according to an embodiment of the present invention.
이하, 첨부된 도면을 참조하여 본 발명의 실시예들을 상세하게 설명하면 다음과 같다. 다만, 본 기재를 설명함에 있어서, 이미 공지된 기능 혹은 구성에 대한 설명은, 본 기재의 요지를 명료하게 하기 위하여 생략하기로 한다.Hereinafter, embodiments of the present invention will be described in detail with reference to the accompanying drawings. However, in describing the present description, a description of a function or configuration that is already known will be omitted in order to clarify the gist of the present description.
공진단(拱辰丹)은 동의보감에 소개되어 있는 한의학상의 처방으로서, 사향, 녹용, 인삼, 당귀, 산수유 및 숙지황의 6가지 생약성분으로 구성되어 있으며, 선천성 허약체질, 무력감, 만성병에 의한 체력 저하, 간 기능 저하로 인한 어지러움, 두통, 만성피로, 월경 이상 등에 효능이 있는 것으로 알려져 있다. 공진단의 주요 성분인 사향(musk)은 사향노루의 사향선(腺)을 건조시켜서 얻는 천연 동물성 향료인데, 사향노루는 현재 멸종위기에 처한 야생 동식물종의 국제거래에 관한 협약(CITES)에 의해서 포획량이 제한되어 있다. 그래서 사향은 가격이 매우 높고 수급이 원활하지 못한 문제가 있기 때문에 이를 대체할 수 있는 생약성분으로서 목향(木香)과 침향(沈香) 등이 주목을 받고 있다. Gongjindan (拱辰丹) is an oriental medicine prescription introduced in Donguibogam. It is composed of six herbal ingredients such as musk, antler, ginseng, angelica, cornus milk, and sukjihwang. It is known to be effective for dizziness, headache, chronic fatigue, and menstrual abnormalities caused by decreased liver function. Musk, the main ingredient of Gongjindan, is a natural animal flavor obtained by drying the musk gland of musk roe deer, and the amount of musk roe deer is captured according to the Convention on International Trade in Wild Animal and Plant Species (CITES), which are currently endangered. This is limited. Therefore, musk incense is very expensive and there is a problem that the supply and demand is not smooth. As a substitute for it, mokhyang (木香) and acupuncture (沈香) are attracting attention.
한편, 향부자는 기운을 순환시키고 뭉친 것을 풀어주는 등 혈기를 다스리는 것으로 알려져 있고, 또한 통증을 완화시키고 월경을 조절하는 기능이 있어서 한방에서 다양한 처방에서 사용되고 있다. 예를 들어 두통이나 복통, 생리불순, 생리통, 자궁출혈, 산후풍, 심리적 불안정으로 인한 가슴통증이나 답답함, 소화불량, 안면홍조, 피부염 등에 사용하는 것으로 알려져 있다. On the other hand, Hyangbuja is known to control blood, such as circulating energy and releasing lumps, and also has a function to relieve pain and control menstruation, so it is used in various prescriptions in oriental medicine. For example, it is known to be used for headache, abdominal pain, menstrual irregularities, menstrual pain, uterine bleeding, postpartum wind, chest pain or stuffiness due to psychological instability, indigestion, facial flushing, and dermatitis.
이러한 점에 착안하여, 본 발명의 발명자들은 연구를 거듭한 결과, 공진단 제조 시, 향부자를 포함하는 한편 전통주인 소주를 배합하고 저온숙성하여 제조하며, 특히, 향부자는 향부자 추출물에 특정 균주를 접종하여 발효시킨 다음, 분획 추출한 분획추출물을 사용하는 경우, 공진단에 가슴통증이나 답답함 해소와 같은 향부자의 효능을 효과적으로 더할 수 있다는 점을 실험을 통하여 확인하고 본 발명을 완성하게 되었다. Focusing on this point, the inventors of the present invention have repeatedly researched, and when manufacturing Gongjindan, the traditional alcoholic soju is blended and low-temperature aging to produce Gongjindan. In particular, Hyangbuja is inoculated with a specific strain in the Hyangbuja extract. After fermentation, it was confirmed through an experiment that when using the fractional extract fractionally extracted, it was confirmed through an experiment that the efficacy of fragrant flavor, such as relieving chest pain or tightness, can be effectively added to the gongjindan.
먼저, 녹용, 당귀, 산수유를 혼합한 후 미세분말화 한다(단계 a).First, after mixing antler, angelica and cornus oil, finely powdered (step a).
녹용은 숫사슴의 갓 자란 뿔을 채취 가공하여 건조한 것을 말하며, 사슴은 매년 3월 중순경부터 늙은 뿔이 떨어지고, 새 뿔이 돋아나기 시작하는데 이대 골질화되지 않은 어린 뿔을 녹용이라 한다. 녹용의 지용성 성분 중 당지질의 일종인 갱글리오사이드(ganglioside)는 신장, 간, 지라, 뇌의 회백질에 축적되어 있는 고분자의 당지질로서 임상실험 결과 신경세포의 전달 장애에 관련된 당뇨병 및 신경독증에 유효한 것으로 알려져 있다. Deer antlers are dried by collecting and processing the freshly grown antlers of a stag. In the deer, old antlers fall off from mid-March every year, and new antlers begin to sprout, and young antlers that are not boneless are called antlers. Among the fat-soluble components of antler, ganglioside, a type of glycolipid, is a polymeric glycolipid accumulated in the gray matter of the kidneys, liver, spleen, and brain. Is known.
한편, 당귀(Angelica gigas)는 미나리과(Umbelliferae)에 속하는 다년생 초본으로 주로 한국, 중국, 일본에 분포하고 있으며, 각 지역에 따라 재배하여 생약 재료로 사용되고 있다. 우리나라에서 재배되고 있는 당귀는 중국당귀(Angelica acutiloba Kitagaw), 일본당귀(Angelica sinensis Diels)와 구분되고 있다. 당귀는 예로부터 약성이 따뜻하고, 맛은 달고, 무독하여 부작용이 없는 생약재로서 질병치료와 건강증진 목적으로 사용해온 우리나라의 대표적인 생약재이다. 국내에 재배되고 있는 당귀의 약효성분으로는 데커신(decursin), 데커시놀(decursinol), 안젤레이트(angelate), 노다케네틴(nodakenetin), 노다케닌 (nodakenin), 움펠리페론(umbelliferone), β-시토스테롤(β-sitosterol), α-피넨(α-pinene), 리모넨(limonene) 등이 함유되어 있다. 특히 당귀의 주요 성분인 쿠마린(Coumarine) 유도체 중에서 데커신, 데커시놀 안젤레이트(decursinol angelate)는 가장 풍부한 구성요소로, 항균, 혈관형성 억제, 항암 등의 약리적인 효과가 알려져 있다.On the other hand, Angelica gigas is a perennial herb belonging to Umbelliferae and is mainly distributed in Korea, China, and Japan, and is cultivated in each region and used as a herbal material. Angelica acutiloba Kitagaw and Japanese angelica sinensis Diels, which are cultivated in Korea, are distinguished. Angelica is a representative herbal medicine in Korea that has been used for disease treatment and health promotion as a herbal medicine with no side effects due to its warm medicinal properties, sweet taste, and non-toxicity. The medicinal ingredients of Angelica Angelica grown in Korea include decursin, decursinol, angelate, nodakenetin, nodakenin, umbelliferone, It contains β-sitosterol, α-pinene, and limonene. In particular, decursin and decursinol angelate are the most abundant constituents among the coumarine derivatives, which are the main components of Angelica Angelica, and are known for their pharmacological effects such as antibacterial, anti-angiogenic, and anti-cancer.
한편, 산수유(Cornusofficinalis)는 층층나무과(Cornaceae)에 속하는 낙엽활엽 소교목으로, 산수유 열매의 육질을 건조한 것으로, 성질은 약간 따뜻하고 맛은 시고 떫으며 독이 없다. 과육(열매)에는 코르닌(cornin), 모로니사이드(morroniside), 로가닌(loganin), 탄닌(tannin), 사포닌(Saponin) 등의 배당체와 포도주산, 사과산, 주석산 등의 유기산이 함유되어 있으며, 그 밖에 비타민 A와 다량의 당도 포함되어 있다. 종자(씨)에는 팔미틴산, 올레인산, 리놀산 등이 함유되어 있다. 산수유는 정수(精髓)를 보(補)해 주고 허리와 무릎을 덥혀 준다. 빈뇨를 낫게 하며, 두풍과 코가 메는 것, 귀먹는 것을 낫게 한다. 또한, 사포닌의 함량이 15% 이상 함유되어 있어 수렴효과가 우수하며, 유해산소 제거 효과도 우수하여 피부를 개선해 주는 효과를 갖는다. 동물실험에서는 이뇨작용과 혈압강하작용을 보이며, 산수유 달인 물은 포도상구균 및 이질균의 억제 작용과 복수암 세포의 억제작용이 있고, 혈당강하작용도 있으며, 심근의 수축력을 높이고, 혈압을 올리며, 면역 계통에 림프세포 증식작용을 보이고, 혈소판 응집억제 작용도 보인다.On the other hand, Cornusofficinalis is a deciduous broad-leaved small arboreous tree belonging to the Cornaceae family. The flesh (fruit) contains glycosides such as cornin, morroniside, loganin, tannin, and saponin, and organic acids such as wine, malic and tartaric acid. In addition, vitamin A and a large amount of sugar are also included. Seeds (seeds) contain palmitic acid, oleic acid, and linoleic acid. Sansuyu provides pure water and warms the waist and knees. It relieves frequent urination, cures head and nose, and deafness. In addition, since it contains more than 15% of saponin, it has an excellent astringent effect, and has an excellent effect of removing harmful oxygen, thus improving the skin. Animal experiments show diuretic and blood pressure-lowering effects, and acid feeding and dysentery have an inhibitory effect on staphylococcus aureus and shigella and ascites cancer cells, lowering blood sugar, increasing myocardial contractility, raising blood pressure, and immunity. It shows lymphocyte proliferation in the lineage and inhibits platelet aggregation.
구체적으로 상기 단계에서 녹용, 당귀 및 산수유는 1 : 0.8 ~ 1.0 : 0.5 ~ 0.7 중량부 비로 혼합되어, 초미분장치를 이용하여 미세분말화를 수행한 것일 수 있다. Specifically, in the above step, antler, angelica and cornus oil are mixed in a ratio of 1: 0.8 to 1.0: 0.5 to 0.7 parts by weight, and fine powdering may be performed using an ultra-fine powder.
다음으로, 상기 혼합 미세분말 100 중량부에 전통소주 또는 청주 40 내지 60 중량부 및 벌꿀 20 내지 30 중량부를 혼합하여 반죽한 다음 55 내지 60 ℃ 온도 범위 내에서 저온 숙성한다(단계 b).Next, 40 to 60 parts by weight of traditional soju or cheongju and 20 to 30 parts by weight of honey are mixed and kneaded with 100 parts by weight of the mixed fine powder, and then aged at a low temperature within a temperature range of 55 to 60°C (step b).
상기 혼합 미세분말에 전통소주 또는 청주를 넣고, 벌꿀을 함께 혼합하여 반죽한 다음, 55 내지 60 ℃ 온도 범위 내에서 저온 숙성을 수행한다. 한편, 상기 벌꿀은 생약의 쓴맛을 효과적으로 중화하기 위해서 포함되는 것으로서, 복용의 편의성을 증가시키는 역할을 수행한다. 한편, 상기와 같은 저온 숙성을 통해, 벌꿀과 전통소주의 향을 보다 진하게 증폭시킬 수 있으며, 상기 범위로 저온 숙성을 수행하지 않는 경우 전통소주의 향과 벌꿀의 풍미가 공진단에 효과적으로 배어들기 어렵다. 한편, 상기 저온 숙성은 0.5 내지 2시간 동안 수행되는 것일 수 있다. Traditional soju or cheongju is added to the mixed fine powder, mixed with honey and kneaded, and then aged at a low temperature within a temperature range of 55 to 60°C. On the other hand, the honey is contained in order to effectively neutralize the bitter taste of the herbal medicine, and serves to increase the convenience of taking. On the other hand, through the low-temperature aging as described above, the aroma of honey and traditional soju can be amplified more intensely, and if the low-temperature aging in the above range is not performed, the scent of traditional soju and the flavor of honey are difficult to effectively penetrate into the gongjindan. Meanwhile, the low-temperature aging may be performed for 0.5 to 2 hours.
다음으로, 상기 숙성된 반죽 100 중량부에 전통소주 또는 청주를 90 내지 110 중량부, 벌꿀 45 내지 55 중량부를 재차 혼합한 다음, 90 내지 110 ℃ 온도 범위의 스팀팟(steam pot)에서 0.5 내지 1.5 시간 고온 숙성한다(단계 c).Next, 90 to 110 parts by weight of traditional soju or cheongju and 45 to 55 parts by weight of honey are mixed again in 100 parts by weight of the aged dough, and then 0.5 to 1.5 in a steam pot in a temperature range of 90 to 110°C. Aged at high temperature for an hour (step c).
저온에서 1차적인 숙성 과정을 거친 반죽에 대하여 전통소주 또는 청주를 다시 배합하고, 벌꿀 또한 재차 혼합한 다음, 상대적으로 고온에서 숙성하는 과정을 수행한다. 한편, 상기와 같은 고온 숙성에 의해 제품 상에 발생할 수 있는 세균 또는 바이러스를 완전히 제거하고, 제품 변질을 효과적으로 막으면서, 보관 기간을 장시간으로 가져갈 수 있는 효과가 있다. 또한, 상기와 같은 고온에서 재차 숙성하는 과정을 거치지 않는 경우, 전통소주의 향과 벌꿀의 풍미를 공진단에 장기간 유지시키기 어려운 문제가 있다. Traditional soju or cheongju is mixed with the dough that has undergone the primary aging process at low temperature, honey is mixed again, and then aged at a relatively high temperature is performed. On the other hand, there is an effect of completely removing bacteria or viruses that may occur on the product by high-temperature aging as described above, effectively preventing product deterioration, and extending the storage period for a long time. In addition, there is a problem in that it is difficult to maintain the aroma of traditional soju and the flavor of honey in Gongjindan for a long time if the process of re-aging at a high temperature as described above is not performed.
다음으로, 상기 숙성된 반죽을 저어준 다음, 0.5 내지 1.5 시간 휴지시키고, 90 내지 110 ℃ 온도 범위의 스팀팟(steam pot)에서 0.5 내지 1.5 시간 재차 고온 숙성한다(단계 d).Next, the aged dough is stirred, rested for 0.5 to 1.5 hours, and aged again at high temperature for 0.5 to 1.5 hours in a steam pot in a temperature range of 90 to 110°C (step d).
한편, 상기와 같이 휴지시킨 후 고온에서 재차 숙성을 거치는 것은 입자를 곱고 부드럽게 하여, 공진단의 복용 시 쉽게 부서져 섭취를 용이하게 하기 위해 수행되는 것이며, 휴지기를 거치는 것은 공진단이 지나치게 눅눅해지는 것을 방지하기 위해 수행되며, 1차적인 고온 숙성 이후 공진단에 과도하게 함유된 수분을 날리기 위해 수행되는 것일 수 있다. On the other hand, re-aging at high temperature after resting as described above is performed to finely and soften the particles and to facilitate ingestion by being easily broken when taking the gongjindan, and passing through the paused period is to prevent the gongjindan from becoming excessively moist. It is performed, and may be performed to blow away moisture contained excessively in the resonance stage after the primary high-temperature aging.
다음으로, 숙성된 반죽을 소나무 원목판에 대어 여러 번 치대어 공기를 제거한다(단계 e). Next, the aged dough is applied to a solid pine wood board and kneaded several times to remove air (step e).
상기 단계에서 공기를 제거하지 않는 경우, 반죽 내에 공기가 포함되어 공진단 섭취 시 소화불량, 복부팽만, 더부룩함 등의 증상을 유발할 수 있기 때문이며, 상기 제거 과정은 약 10 내지 30분간 반복적으로 치대어 수행되는 것일 수 있다. If the air is not removed in the above step, it is because air is contained in the dough and may cause symptoms such as indigestion, abdominal distension, and bloating when ingesting the gongjindan, and the removal process is performed by repeatedly kneading for about 10 to 30 minutes. It can be.
다음으로, 상기 반죽에 침향 및 향부자를 혼합한 다음, 0.5 내지 1.5 시간 추가로 반죽한다(단계 f). Next, acupuncture and flavor are mixed with the dough, and then additionally kneaded for 0.5 to 1.5 hours (step f).
침향(Aquillaria agallocha Roxburgh)은 침향나무에 천연적으로 분비된 수지가 침착하여 그 심재 부위에 조직학적으로 단단한 덩어리 모양을 이루고 있는 부분이다. 침향은 동물실험에서 진정작용이 있는 것으로 확인되었으며, 추출액은 결핵균을 억제시키고 장티프스균 및 적리균에 대해서도 강력한 억제효과를 보인 것으로 보고되어 있다.Aquillaria agallocha Roxburgh (Aquillaria agallocha Roxburgh) is a part that forms a histologically hard mass in the heartwood area by depositing naturally secreted resin on the aloes tree. Acupuncture was found to have a sedative effect in animal experiments, and the extract was reported to inhibit Mycobacterium tuberculosis and to have a strong inhibitory effect on Typhoid bacteria and Red Lycobacteria.
한편, 향부자(Cyprus rotundus L.)는 기운을 순환시키고 뭉친 것을 풀어주는 등 혈기를 다스리는 것으로 알려져 있고, 또한 통증을 완화시키고 월경을 조절하는 기능이 있어서 한방에서 다양한 처방에서 사용되고 있다. 예를 들어 두통이나 복통, 생리불순, 생리통, 자궁출혈, 산후풍, 심리적 불안정으로 인한 가슴통증이나 답답함, 소화불량, 안면홍조, 피부염 등에 사용하는 것으로 알려져 있다.On the other hand, Hyangbuja (Cyprus rotundus L.) is known to control blood circulation such as circulating energy and releasing lumps, and also has a function to relieve pain and regulate menstruation, so it is used in various prescriptions in oriental medicine. For example, it is known to be used for headache, abdominal pain, menstrual irregularities, menstrual pain, uterine bleeding, postpartum wind, chest pain or stuffiness due to psychological instability, indigestion, facial flushing, and dermatitis.
한편, 상기 단계에서 반죽 100 중량부를 기준으로 침향은 30 내지 50 중량부, 향부자는 60 내지 80 중량부로 혼합하였다. On the other hand, in the above step, based on 100 parts by weight of the dough, acupuncture was mixed in 30 to 50 parts by weight, and flavored in 60 to 80 parts by weight.
한편, 상기 f 단계에서 사용되는 향부자는 향부자 추출물에 1종 이상의 균주를 접종하여 발효시킨 것으로서, 락토바실러스 부크네리(Lactobacillus buchneri), 락토바실러스 파라카제이(Lactobacillus paracasei subsp. tolerans), 락토바실러스 하르비넨시스(Lactobacillus harbinensis), 사카로마이콥시스 피불리게라(Saccharomycopsis fibuligera) 및 피치아 쿠드리아브제비(Pichia kudriavzevii)로 이루어지는 군에서 선택되는 1종 이상의 균주를 혼합하여 발효시킨 것일 수 있다.On the other hand, Hyangbuja used in step f is fermented by inoculating Hyangbuja extract with one or more strains, Lactobacillus buchneri , Lactobacillus paracasei subsp. tolerans ), Lactobacillus harbinen Cis ( Lactobacillus harbinensis ), Saccharomycopsis fibuligera (Saccharomycopsis fibuligera) And Pichia kudriavzevii (Pichia kudriavzevii) It may be fermented by mixing one or more strains selected from the group consisting of.
구체적으로 향부자 추출물은 물 또는 에탄올, 상세하게는 50% 에탄올을 이용하여 추출한 것일 수 있으며, 상기 발효 단계는 31 내지 38 ℃ 온도 조건에서 24 내지 36시간 동안 수행되는 것일 수 있다. Specifically, the Hyangbuja extract may be extracted using water or ethanol, specifically 50% ethanol, and the fermentation step may be performed for 24 to 36 hours at a temperature condition of 31 to 38°C.
한편, 상기 발효는 OD 600 흡광도 값에서 2.0 내지 7.0의 균수에서 미생물을 접종하고, 25 내지 37 ℃ 조건에서 24 내지 72 시간 동안 수행되는 것일 수 있다. 구체적으로, OD 600 흡광도에서 2.0 보다 적은 균으로 발효를 수행하는 경우 균이 생장되지 않을 수 있는 문제점이 있고, OD 600 흡광도에서 7.0 보다 많은 균으로 발효를 수행하면 오염된 균이 접종될 수 있는 문제점이 있다. On the other hand, the fermentation may be performed by inoculating microorganisms in a number of bacteria of 2.0 to 7.0 at an absorbance value of OD 600 and performing for 24 to 72 hours at 25 to 37 °C. Specifically, when fermentation is performed with bacteria less than 2.0 at OD 600 absorbance, there is a problem that bacteria may not grow, and when fermentation is performed with more bacteria than 7.0 at OD 600 absorbance, contaminated bacteria may be inoculated. There is this.
한편, 상기 발효 단계 이후 향부자는 부탄올, 아세톤, 인산, 헥산, 에탄올 및 물로 이루어지는 군에서 선택되는 1종 이상의 분획용매로 분획하여 얻은 발효 분획추출물일 수 있으며, 상기 분획물을 사용하는 경우, 공진단에 향부자의 유효성분을 충분히 포함시킬 수 있게 된다. On the other hand, after the fermentation step, the fragrance may be a fermentation fraction extract obtained by fractionation with one or more fractionation solvents selected from the group consisting of butanol, acetone, phosphoric acid, hexane, ethanol and water. It is possible to sufficiently include the active ingredients of.
마지막으로, 상기 f 단계에서 얻어진 반죽을 5g씩 떼어내어 구형의 환으로 제조한 다음 금박을 입힌다(단계 e).Finally, 5 g of the dough obtained in step f is removed each to form a spherical ring, and then coated with gold leaf (step e).
상기 금박은 순도 95% 이상인 순금을 1 ~ 400㎚ 크기의 나노분말로 하되, 공진단 1개당 대략 0.001 내지 0.1g 범위에서 도포되도록 할 수 있다. The gold foil is made of pure gold having a purity of 95% or more as a nanopowder having a size of 1 to 400 nm, and may be applied in a range of about 0.001 to 0.1 g per one resonant end.
발명을 하기의 실시예에서 보다 상세하게 설명한다. 단, 하기의 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기의 실시예에 의하여 한정되는 것은 아니다.The invention will be described in more detail in the following examples. However, the following examples are merely illustrative of the present invention, and the contents of the present invention are not limited by the following examples.
[실시예] [Example]
실시예 1Example 1
녹용, 당귀, 산수유를 깨끗이 세척하여 준비한 다음, 이를 1 : 0.8 : 0.6 중량부 비로 하여, 혼합하고, 초미분장치를 이용하여 미세분말화 하였다. 다음으로, 상기 혼합 미세분말 100 중량부를 기준으로 청주 50 중량부, 벌꿀 25 중량부를 혼합하여 반죽화한 다음, 60 ℃ 온도 조건 하에서 수비드(Sous-vide) 장치로 1시간 동안 저온 숙성하였다. After the antler, angelica and cornelian oil were cleaned and prepared, the ratio was 1:0.8:0.6 parts by weight, mixed, and finely powdered using an ultra-fine powder. Next, 50 parts by weight of sake and 25 parts by weight of honey were mixed and kneaded based on 100 parts by weight of the mixed fine powder, followed by low-temperature aging for 1 hour in a Sous-vide device under a temperature condition of 60°C.
다음으로, 상기 저온 숙성된 반죽을 꺼내어 30도의 전통소주를 반죽 100 중량부 기준으로 100 중량부, 벌꿀 50 중량부를 재차 혼합하고, 100 ℃의 스팀팟(steam pot)에서 1시간 동안 고온 숙성을 진행하였다. 상기 고온 숙성 후 1시간 동안 휴지시키고, 100 ℃의 스팀팟(steam pot)에서 1시간 동안 고온 숙성을 재차 진행하였다. Next, take out the low-temperature aging dough, mix 100 parts by weight of traditional soju at 30°C and 50 parts by weight of honey again based on 100 parts by weight of the dough, and proceed to high temperature aging for 1 hour in a 100°C steam pot I did. After the high-temperature aging, it was paused for 1 hour, and the high-temperature aging was again performed for 1 hour in a 100°C steam pot.
다음으로, 숙성된 반죽을 소나무 원목판에 대어 약 15분간 여러 번 치대어 공기를 제거하였으며, 여기에 침향 및 향부자를 반죽 100 중량부를 기준으로 침향 40 중량부, 향부자 70 중량부를 혼합하고, 추가로 반죽한 다음, 이를 5g씩 떼어내어 환으로 제조한 다음, 1개당 0.005g의 금박을 씌워 공진단을 제조하였다. Next, the aged dough was put on a solid pine board and kneaded several times for about 15 minutes to remove air, and 40 parts by weight of acupuncture and 70 parts by weight of acupuncture were mixed based on 100 parts by weight of the dough. After kneading, 5g of this was removed each to form a ring, and then 0.005g of gold leaf was covered per piece to prepare Gongjindan.
한편, 상기 사용된 향부자는 향부자를 물에 혼합한 다음, 80℃ 온도에서 24 시간 동안 열수 추출하여 오미자 열수 추출물을 수득한 다음, 여기에 락토바실러스 파라카제이 톨레랑스(Lactobacillus paracasei sub. Tolerans) 균주를 접종하고, 35℃ 온도 조건에서 30 시간 발효하여 얻은 향부자 발효추출물을 사용하였다. Meanwhile, the used Hyangbuja was mixed with Hyangbuja in water and then extracted with hot water at 80°C for 24 hours to obtain a hot water extract of Schisandra chinensis, and then Lactobacillus paracasei sub. Tolerans strain was added thereto. After inoculation, a fermented extract obtained by fermenting for 30 hours at 35°C was used.
실시예 2Example 2
상기 실시예 1 과 동일한 방법으로 공진단을 제조하되, 향부자 발효추출물을 헥산으로 분획처리하여 얻은 분획추출물을 사용한 것만 달리하였다. Gongjindan was prepared in the same manner as in Example 1, except that the fractionated extract obtained by fractionating the fermented extract of Hyangbuja with hexane was used.
비교예 1-1Comparative Example 1-1
상기 실시예 1 과 동일한 방법으로 공진단을 제조하되, 저온 숙성 과정을 거치지 아니하였다. Gongjindan was prepared in the same manner as in Example 1, but the low-temperature aging process was not performed.
비교예 1-2Comparative Example 1-2
상기 실시예 1 과 동일한 방법으로 공진단을 제조하되, 1차 고온 숙성 과정을 거치지 아니하였다. The gongjindan was manufactured in the same manner as in Example 1, but the first high-temperature aging process was not performed.
비교예 1-3Comparative Example 1-3
상기 실시예 1 과 동일한 방법으로 공진단을 제조하되, 2차 고온 숙성 과정을 거치지 아니하였다. The gongjindan was manufactured in the same manner as in Example 1, but the second high-temperature aging process was not performed.
비교예 1-4Comparative Example 1-4
상기 실시예 1 과 동일한 방법으로 공진단을 제조하되, 1차 및 2차 고온 숙성 과정을 모두 거치지 아니하였다. The gongjindan was manufactured in the same manner as in Example 1, but both the first and second high-temperature aging processes were not performed.
비교예 2Comparative Example 2
상기 실시예 1 과 동일한 방법으로 공진단을 제조하되, 향부자를 혼합하지 아니하였다. Gongjindan was prepared in the same manner as in Example 1, but the flavor was not mixed.
비교예 3-1Comparative Example 3-1
상기 실시예 1 과 동일한 방법으로 공진단을 제조하되, 향부자 발효 과정을 35℃ 온도 조건에서 10시간 동안 수행한 것만 달리하였다. Gongjindan was prepared in the same manner as in Example 1, except that the flavor fermentation process was performed at 35°C for 10 hours.
비교예 3-2Comparative Example 3-2
상기 실시예 1 과 동일한 방법으로 공진단을 제조하되, 향부자 발효 과정을 35℃ 온도 조건에서 40시간 동안 수행한 것만 달리하였다. Gongjindan was prepared in the same manner as in Example 1, except that the flavor fermentation process was performed at 35°C for 40 hours.
[실험 1. 관능평가 시험][Experiment 1. Sensory evaluation test]
상술한 실시예 및 비교예에서 제조된 공진단을 준비하고, 성인 남녀 20명을 대상으로 복용하도록 하였으며, 12시간 경과된 후, 5점 항목 척도법(5점: 대단히 좋음, 1점: 나쁨)을 활용해 소화불량 완화 여부, 통증 완화 여부 , 쓴맛 마스킹 여부, 및 전체적인 기호도에 대하여 관능평가를 실시하였다. 구체적인 결과는 다음의 표 1에 나타내었다. The Gongjindan prepared in the above-described Examples and Comparative Examples was prepared, and 20 men and women were to be taken, and after 12 hours, a 5-point scale method (5 points: very good, 1 point: bad) was used. Sensory evaluation was conducted on whether to relieve dyspepsia, pain relief, bitter taste masking, and overall acceptability. Specific results are shown in Table 1 below.
표 1의 결과에서 나타난 바와 같이, 본 발명의 실시예 1 및 2에 따라 제조된 공진단의 경우, 비교예들 대비 소화불량 완화 여부, 통증 완화 여부, 쓴맛 마스킹 여부, 및 전체적인 기호도 측면에서 모두 우수한 점수를 획득한 것을 확인할 수 있었다. 특히, 최적화된 조건 하에서 발효처리 수행된, 향부자 발효추출물 또는 향부자 발효 분획추출물을 사용하는 경우, 섭취한 피험자에 대하여 소화불량 완화 여부 통증 완화 여부 등 효과가 현저히 향상된 것을 확인할 수 있었다. As shown in the results of Table 1, in the case of the Gongjindan prepared according to Examples 1 and 2 of the present invention, compared to the comparative examples, all of the excellent scores in terms of dyspepsia relief, pain relief, bitter taste masking, and overall preference It was able to confirm that obtained was obtained. In particular, in the case of using the fermentation treatment performed under the optimized conditions, the fermentation extract or the fermentation fraction extract of the fermentation, it was confirmed that the effects such as relief of indigestion or pain relief for the ingested subject were remarkably improved.
앞에서, 본 발명의 특정한 실시예가 설명되고 도시되었지만 본 발명은 기재된 실시예에 한정되는 것이 아니고, 본 발명의 사상 및 범위를 벗어나지 않고 다양하게 수정 및 변형할 수 있음은 이 기술의 분야에서 통상의 지식을 가진 자에게 자명한 일이다. 따라서, 그러한 수정예 또는 변형예들은 본 발명의 기술적 사상이나 관점으로부터 개별적으로 이해되어서는 안되며, 변형된 실시예들은 본 발명의 특허청구범위에 속한다 하여야 할 것이다.In the above, although specific embodiments of the present invention have been described and illustrated, the present invention is not limited to the described embodiments, and various modifications and variations can be made without departing from the spirit and scope of the present invention. It is self-evident to those who have. Therefore, such modifications or variations should not be individually understood from the technical spirit or point of view of the present invention, and the modified embodiments should be said to belong to the claims of the present invention.
Claims (5)
b) 상기 혼합 미세분말 100 중량부에 전통소주 또는 청주 40 내지 60 중량부 및 벌꿀 20 내지 30 중량부를 혼합하여 반죽한 다음 55 내지 60 ℃ 온도 범위 내에서 0.5 내지 2 시간 저온 숙성하는 단계;
c) 상기 숙성된 반죽 100 중량부에 전통소주 또는 청주를 90 내지 110 중량부, 벌꿀 45 내지 55 중량부를 재차 혼합한 다음, 90 내지 110 ℃ 온도 범위의 스팀팟(steam pot)에서 0.5 내지 1.5 시간 고온 숙성하는 단계;
d) 상기 숙성된 반죽을 저어준 다음, 0.5 내지 1.5 시간 휴지시키고, 90 내지 110 ℃ 온도 범위의 스팀팟(steam pot)에서 0.5 내지 1.5 시간 재차 고온 숙성하는 단계;
e) 상기 숙성된 반죽을 소나무 원목판에 대어 여러 번 치대어 공기를 제거하는 단계;
f) 상기 반죽에 침향 및 향부자를 혼합한 다음, 0.5 내지 1.5 시간 추가로 반죽하는 단계; 및
g) 상기 f 단계에서 얻어진 반죽을 5g씩 떼어내어 구형의 환으로 제조한 다음 금박을 입히는 단계; 를 포함하는, 공진단 제조방법.
a) mixing antler, angelica and cornus oil, and then finely powdering it;
b) mixing and kneading 40 to 60 parts by weight of traditional soju or cheongju and 20 to 30 parts by weight of honey to 100 parts by weight of the mixed fine powder and then aging at a low temperature for 0.5 to 2 hours within a temperature range of 55 to 60°C;
c) 90 to 110 parts by weight of traditional soju or cheongju and 45 to 55 parts by weight of honey are mixed again with 100 parts by weight of the aged dough, and then 0.5 to 1.5 hours in a steam pot in the temperature range of 90 to 110°C. High-temperature aging;
d) stirring the aged dough, resting for 0.5 to 1.5 hours, and aging again at high temperature for 0.5 to 1.5 hours in a steam pot in a temperature range of 90 to 110°C;
e) applying the aged dough to the solid pine wood board and kneading it several times to remove air;
f) mixing the aloes and flavoring in the dough, and then kneading for 0.5 to 1.5 hours; And
g) removing the dough obtained in step f by 5g to form a spherical ring and then coating gold leaf; Containing, Gongjindan manufacturing method.
상기 a 단계에서 녹용, 당귀 및 산수유는 1 : 0.8 내지 0.9 : 0.5 내지 0.7 중량부 비로 혼합되는 것인, 공진단 제조방법.
The method of claim 1,
In the step a, deer antler, angelica and cornus oil are mixed in a ratio of 1: 0.8 to 0.9: 0.5 to 0.7 parts by weight.
상기 f 단계의 향부자는 향부자 추출물에 1종 이상의 균주를 접종하여 발효시킨 것으로서, 락토바실러스 부크네리(Lactobacillus buchneri), 락토바실러스 파라카제이(Lactobacillus paracasei subsp. tolerans), 락토바실러스 하르비넨시스(Lactobacillus harbinensis), 사카로마이콥시스 피불리게라(Saccharomycopsis fibuligera) 및 피치아 쿠드리아브제비(Pichia kudriavzevii)로 이루어지는 군에서 선택되는 1종 이상의 균주를 혼합하여 발효시킨 것인, 공진단 제조방법.
The method of claim 1,
Hyangbuja in step f is fermented by inoculating Hyangbuja extract with one or more strains, Lactobacillus buchneri , Lactobacillus paracasei subsp. tolerans ), and Lactobacillus harbinensis. ), Saccharomycopsis fibuligera And Pichia kudriavzevii (Pichia kudriavzevii) is fermented by mixing one or more strains selected from the group consisting of, Gongjindan manufacturing method.
상기 발효는 31 내지 38 ℃ 온도 조건에서 24 내지 36시간 동안 수행되는, 공진단 제조방법.
The method of claim 3,
The fermentation is performed for 24 to 36 hours at 31 to 38 °C temperature condition, Gongjindan manufacturing method.
상기 발효 후 향부자는 부탄올, 아세톤, 인산, 헥산, 에탄올 및 물로 이루어지는 군에서 선택되는 1종 이상의 분획용매로 분획하여 얻은 발효 분획추출물인, 공진단 제조방법.The method of claim 3,
After the fermentation, flavor is a fermented fraction extract obtained by fractionating with one or more fractionation solvents selected from the group consisting of butanol, acetone, phosphoric acid, hexane, ethanol, and water.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200114940A KR102238374B1 (en) | 2020-09-08 | 2020-09-08 | Manufacturing method of gongjindan |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200114940A KR102238374B1 (en) | 2020-09-08 | 2020-09-08 | Manufacturing method of gongjindan |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102238374B1 true KR102238374B1 (en) | 2021-04-09 |
Family
ID=75443953
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200114940A KR102238374B1 (en) | 2020-09-08 | 2020-09-08 | Manufacturing method of gongjindan |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102238374B1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101520413B1 (en) * | 2013-01-31 | 2015-05-14 | 대전대학교 산학협력단 | Composition for promoting digestion containing medicinal herb and microorganism |
KR20150073913A (en) | 2015-06-11 | 2015-07-01 | 진용희 | Gongjindan of minimizing active component loss and method manufacturing thereof |
KR20160049751A (en) | 2014-10-28 | 2016-05-10 | 주식회사 위드내추럴 | Gongjindan composition comprising bear gall and fabricating method thereof |
KR20160049750A (en) | 2014-10-28 | 2016-05-10 | 주식회사 위드내추럴 | Fermented gongjindan composition and fabricating method thereof |
KR20160119999A (en) * | 2015-04-07 | 2016-10-17 | 이원복 | Gongjindan based on dongibogam and method of manufacturing the same |
KR20200103995A (en) * | 2019-02-26 | 2020-09-03 | 홍광희 | Pills for health supplements and methods for manufacturing same |
-
2020
- 2020-09-08 KR KR1020200114940A patent/KR102238374B1/en active IP Right Grant
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101520413B1 (en) * | 2013-01-31 | 2015-05-14 | 대전대학교 산학협력단 | Composition for promoting digestion containing medicinal herb and microorganism |
KR20160049751A (en) | 2014-10-28 | 2016-05-10 | 주식회사 위드내추럴 | Gongjindan composition comprising bear gall and fabricating method thereof |
KR20160049750A (en) | 2014-10-28 | 2016-05-10 | 주식회사 위드내추럴 | Fermented gongjindan composition and fabricating method thereof |
KR20160119999A (en) * | 2015-04-07 | 2016-10-17 | 이원복 | Gongjindan based on dongibogam and method of manufacturing the same |
KR20150073913A (en) | 2015-06-11 | 2015-07-01 | 진용희 | Gongjindan of minimizing active component loss and method manufacturing thereof |
KR20200103995A (en) * | 2019-02-26 | 2020-09-03 | 홍광희 | Pills for health supplements and methods for manufacturing same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101544532B1 (en) | Composition comprising an extract of Cynanchi wilfordii for preventing or treating of climacteric disorder | |
KR101880894B1 (en) | Food composition comprising the mixed herbal extract as an active ingredient | |
CN104694353B (en) | Health care wine for lady and preparation method thereof | |
KR102012732B1 (en) | The skin cosmetic composition for anti-inflammation and reducing the skin pore comprising natural complex extracts | |
KR20180137174A (en) | Health supplementing food for enhancing hair restoration, alleviating and improving hair loss | |
KR102243873B1 (en) | Fermented pills for reducing and preventing premature dementia and manufacturing methods thereof | |
CN105941714A (en) | Herbal tea beverage capable of clearing away heat and removing fire and preparation method of herbal tea beverage | |
KR102176938B1 (en) | Cosmetic Composition Comprising Fermented Liquor of Natural Plant and Preparation Methods Thereof | |
KR102174660B1 (en) | Cosmetic Composition Comprising Fermented Liquor and Powder of Natural Plant and Preparation Methods Thereof | |
CN105660958A (en) | Preparation method of lotus leaf and lotus seed tea | |
KR20190057618A (en) | Ripe persimmon jelly comprising herbal ingredients and manufacturing method thereof | |
CN112515013A (en) | Preparation method of jasmine flower-flavored golden flower dark tea bag | |
KR101787337B1 (en) | the fermented samultang extracting method with the function of both anti-oxidation and immunity and the samultang extract using thereof | |
KR102238374B1 (en) | Manufacturing method of gongjindan | |
KR20200107444A (en) | The skin cosmetic composition for anti-oxidation and anti-wrinkle of skin comprising natural complex extracts | |
KR101788246B1 (en) | Method for manufacturing fermented mistletoe and method for producing concentrate and jellystick thereof | |
KR101566822B1 (en) | Cosmetic containing herb extracts for improving atopic dermatitis | |
KR102211523B1 (en) | Pills for health foods and methods for manufacturing same | |
CN106618128A (en) | Green environmental protection joss stick and its preparation method thereof | |
CN105941715A (en) | Tea bag capable of clearing away heat and removing fire and preparation method of tea bag | |
CN110804518A (en) | Preparation method of jasmine flower wine | |
KR101684869B1 (en) | Bath agent containing ceriporia lacerata extract | |
KR101884627B1 (en) | Composition comprising natural herbs essential having antibiotic activity and process thereof | |
CN109170029A (en) | A kind of clearing heat and moistening dryness mandarin orange tire health preserving tea | |
KR102699337B1 (en) | Immune-boosting composition comprising Angelica extract and Aster glehni extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |